Balaxi Pharmaceuticals Ltd Annually Results

Gross Sales

292.56

241.29

336.43

279.39

231.33

Excise Duty

0

0

0

0

0

Net Sales

292.56

241.29

336.43

279.39

231.33

Other Operating Income

0

0

0

0

0

Other Income

-3.72

-2.65

2.64

4.97

2.23

Total Income

288.84

238.65

339.07

284.36

233.56

Total Expenditure

255.35

194.56

279.89

229.18

188.92

PBIDT

33.5

44.08

59.17

55.18

44.64

Interest

2.93

1.68

0.5

0.14

0.01

PBDT

30.56

42.41

58.67

55.03

44.63

Depreciation

1.89

2.1

1.75

0.51

0.3

Minority Interest Before NP

0

0

0

0

0

Tax

3.7

4.51

9.9

6.83

6.19

Deferred Tax

-0.1

-0.11

1.06

0.03

0

Reported Profit After Tax

25.07

35.91

45.96

47.66

38.14

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

25.07

35.91

45.96

47.66

38.14

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

25.07

35.91

45.96

47.66

38.14

EPS (Unit Curr.)

4.54

-2.32

45.81

47.66

38.14

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

5

0

Equity

11.04

10.9

10.18

10

10

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

11.45

18.26

17.58

19.75

19.29

PBDTM(%)

10.44

17.57

17.43

19.69

19.29

PATM(%)

8.56

14.88

13.66

17.05

16.48